Capital Investment Counsel Inc’s AbbVie ABBV Stock Holding History

Capital Investment Counsel Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$405K	Sell	1,610 -43	-3%	-$9.25K	0.04%	145
2026 Q1	$360K	Buy	1,653 +28	+2%	+$6.21K	0.04%	146
2025 Q4	$371K	Hold	1,625	–	–	0.04%	147
2025 Q3	$376K	Sell	1,625 -454	-22%	-$92.5K	0.05%	147
2025 Q2	$386K	Buy	2,079 +1,025	+97%	+$190K	0.05%	137
2025 Q1	$221K	Buy	+1,054	New	+$205K	0.03%	176
2024 Q4	–	Sell	-1,329	Closed	-$262K	–	247
2024 Q3	$262K	Buy	1,329 +69	+5%	+$12.9K	0.04%	161
2024 Q2	$216K	Hold	1,260	–	–	0.03%	173
2024 Q1	$229K	Buy	+1,260	New	+$217K	0.04%	170
2022 Q3	–	Sell	-1,313	Closed	-$201K	–	156
2022 Q2	$201K	Buy	1,313 +41	+3%	+$6.26K	0.05%	159
2022 Q1	$206K	Buy	+1,272	New	+$185K	0.04%	168

Other funds holding ABBV

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Capital Investment Counsel Inc's ABBV Position: Q2 2026 in Review

Capital Investment Counsel Inc reduced its AbbVie (ABBV) stake by 2.6% in Q2 2026, selling an estimated $9.25K and leaving 1,610 shares worth $405K. The position accounts for 0.04% of the portfolio, ranked #145.

Capital Investment Counsel Inc first reported a position in ABBV in Q1 2022 and has held it in 11 quarters since. 2,642 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Capital Investment Counsel Inc held 1,610 shares of AbbVie worth $405K as of Q2 2026.
Capital Investment Counsel Inc sold 43 AbbVie shares in Q2 2026, an estimated $9.25K.
AbbVie made up 0.04% of Capital Investment Counsel Inc's portfolio in Q2 2026, its #145 holding.
Capital Investment Counsel Inc first reported a position in AbbVie in Q1 2022 and has held it in 11 quarters since.
2,642 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Capital Investment Counsel Inc's 13F filing for Q2 2026, filed 27 Jul 2026.